What We're Reading: Page 41
Industry reads hand-picked by our editors
Oct 23, 2024
-
The New York Times
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
-
Stat News
Novo asks FDA to bar compounders from making semaglutide copies
-
The Wall Street Journal
Cancer Care Is Getting Personal. Local Doctors Can’t Keep Up.
-
The Guardian
Alzheimer’s drug rejected for widespread NHS use in England
Oct 22, 2024
-
The Wall Street Journal
J&J’s Ketamine-Derived Drug Is Taking Off
-
The New York Times
First Sickle Cell Gene Therapy Patient, 12, Leaves Hospital
-
FirstWord Pharma
HIV weekly combo from Gilead, Merck & Co. achieves long-term viral suppression
Oct 21, 2024
-
The Wall Street Journal
Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue
-
Axios
Harris faces fight over Lina Khan’s future
-
The Washington Post
Dementia risk linked to serious infections, study shows
-
AP News
Three states try to make abortion pill mifepristone harder to access
Oct 18, 2024
-
Bloomberg
Merck CEO Belen Garijo Scoffs at Chasing After Weight-Loss Drug Hype
-
MIT Technology Review
Oropouche virus is spreading. Here’s what we know.
-
MedTech Dive
Legacy medical devices keep regulators up at night
-
The Boston Globe
Biotech CEO faces controversy over New Hampshire puppy store
Oct 17, 2024
Oct 16, 2024
Oct 15, 2024
-
Financial Times
France warns it could block €15.5bn Sanofi consumer health deal
-
MIT Technology Review
A data bottleneck is holding AI science back, says new Nobel winner
-
Barron’s
PBMs’ Backroom Negotiations Revealed in Confidential Files
-
C&EN
Hijacking kinases to kill cancer
Previous
